Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 and the Kidney: From Epidemiology to Clinical Practice.
Gagliardi I, Patella G, Michael A, Serra R, Provenzano M, Andreucci M. Gagliardi I, et al. Among authors: patella g. J Clin Med. 2020 Aug 4;9(8):2506. doi: 10.3390/jcm9082506. J Clin Med. 2020. PMID: 32759645 Free PMC article. Review.
Aortic Aneurysms, Chronic Kidney Disease and Metalloproteinases.
Andreucci M, Provenzano M, Faga T, Michael A, Patella G, Mastroroberto P, Serraino GF, Bracale UM, Ielapi N, Serra R. Andreucci M, et al. Among authors: patella g. Biomolecules. 2021 Jan 30;11(2):194. doi: 10.3390/biom11020194. Biomolecules. 2021. PMID: 33573220 Free PMC article. Review.
Marinobufagenin, left ventricular geometry and cardiac dysfunction in end-stage kidney disease patients.
Bolignano D, De Rosa S, Greco M, Presta P, Patella G, Crugliano G, Sabatino J, Strangio A, Romano LR, Comi A, Cianfrone P, Andreucci M, Dragone F, Indolfi C, Foti DP, Coppolino G. Bolignano D, et al. Among authors: patella g. Int Urol Nephrol. 2022 Oct;54(10):2581-2589. doi: 10.1007/s11255-022-03161-0. Epub 2022 Mar 10. Int Urol Nephrol. 2022. PMID: 35274285
Hyperkalemia in CKD: an overview of available therapeutic strategies.
Costa D, Patella G, Provenzano M, Ielapi N, Faga T, Zicarelli M, Arturi F, Coppolino G, Bolignano D, De Sarro G, Bracale UM, De Nicola L, Chiodini P, Serra R, Andreucci M. Costa D, et al. Among authors: patella g. Front Med (Lausanne). 2023 Jul 31;10:1178140. doi: 10.3389/fmed.2023.1178140. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37583425 Free PMC article. Review.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
12 results